Table 1. Baseline parameters.
| Baseline Characteristics | Acute Stenting with Tirofiban n = 60 | Acute MCA thrombectomy without Tirofiban n = 135 | p Value |
|---|---|---|---|
| Male gender | 38 (63%) | 55 (41%) | p = 0.004 |
| Median age in years (IQR) | 71 (61–77) | 76 (69–82) | p = 0.004 |
| Median NIHSS Score (IQR) | 11 (6–16) | 15 (11–18) | p<0.001 |
| Arterial hypertension | 48 (80%) | 116 (86%) | p = 0.296 |
| Diabetes mellitus | 7 (12%) | 38 (28%) | p = 0.012 |
| Atrial fibrillation | 15 (25%) | 74 (55%) | p<0.001 |
| Hyperlipidemia | 36 (60%) | 61 (45%) | p = 0.056 |
| Smoking | 20 (33%) | 12 (9%) | p<0.001 |
| Previous stroke | 6 (10%) | 13 (10%) | p = 0.936 |
| Coronary heart disease | 7 (12%) | 23 (17%) | p = 0.337 |
| Bridging i.v. thrombolysis | 48 (80%) | 116 (86%) | p = 0.296 |
| Time from symptom onset to i.v. thrombolysis in minutes (IQR) | 88 (63–128) | 82 (62–120) | p = 0.712 |
| Time from symptom onset to groin puncture in minutes (IQR) | 175 (139–238) | 183 (143–294) | p = 0.325 |
| Time from symptom onset to recanalization in minutes(IQR) | 263 (217–332) | 264 (207–356) | p = 0.646 |
| Median pretreatment ASPECTS (IQR) | 10 (9.75–10) | 10 (9–10) | p = 0.042 |
| Median posttreatment ASPECTS (IQR) | 8 (7–9) | 7 (5–8) | p = 0.007 |
| TICI Score ≥ 2b | 54 (90%) | 103 (76%) | p = 0.026 |